Just over two weeks ago, we were delighted to hear at Myeloma Australia the changes to the pharmaceutical benefit scheme (PBS) listing for Pomalidomide (Pomalyst®). Whilst the notation was slight, the...
Copyright © 2010 - 2024 Myeloma Foundation of Australia Inc . All rights reserved. Hosted by Zenhosting